For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...

From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...

Advanced Parkinson's disease patients in Calgary have had access since 2024 to a treatment called Vyalev, which an Edmonton ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Parkinson's disease is the fastest growing neurological disorder in the world. Its prevalence has more than doubled in the past 25 years and will triple again by 2050. Behind these numbers lie ...

Scientists have identified the role of an ion channel that plays a key part in how cells break down and recycle components, a discovery that could open the door to new treatment strategies for ...

After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, forms an abnormal connection with an enzyme called ClpP. This enzyme normally ...